Check · Environmental · Microplastics In review

Are microplastics making you sick, and do you need a detox to remove them?

Claim attributed to Detox and wellness marketers (apheresis/"blood cleanse" clinics, supplement sellers) , No single named claimant, this is a recurring marketing frame. The only human "removal" data come from, or are co-authored by people affiliated with, commercial apheresis/plasma-exchange providers (INUS Medical Center AG, TKM Sub Health Laboratory GmbH, Transmedac Innovations AG; Circulate Health), which sell the procedure.

Verdict Mixed

Evidence grade C Low certainty

The claim bundles three things and grades differently on each: that plastic is in our bodies (true and well-replicated), that it is making us sick (biologically plausible but unproven in humans), and that you need a detox to remove it (unsupported, untested for any health benefit and sold by the people who studied it).

Plastic is genuinely in your blood; whether it is harming you is unproven, and the cleanse that promises to remove it leaches plastic from its own tubing and has never been shown to make anyone healthier.

The theory

What it’s supposed to target

Particle bioaccumulation
Endocrine disruptors (phthalates, BPA)
Oxidative stress / inflammation
Tissue translocation

Two mechanisms sit behind microplastics worry. First, physical: tiny particles now turn up in human blood, gut and tissue and could cause local inflammation or oxidative stress. Second, chemical: plastics carry additives like phthalates and BPA that act as endocrine disruptors, mimicking or blocking hormones. The detox-product theory then assumes these accumulate and that a cleanse can pull them out.

The exposure is real and the additive chemistry is a legitimate, actively studied concern. The weak links are dose and removal: it is not yet established what particle burden causes what harm in humans, and there is no evidence that any detox supplement, cleanse or protocol clears microplastics from your body. A genuine emerging exposure attached to a detox solution that does not exist.

Mechanism is theory, not proof. A plausible pathway explains why something might work, not whether it does. The verdict rests on the evidence below, not the elegance of the theory.

The claim

What would have to be true

Microplastics enter and lodge in the body, HOLDS: detected in blood, placenta and arterial plaque.

Those particles cause measurable disease in humans, UNPROVEN: only an observational association exists, with contamination and confounding caveats.

A treatment removes the accumulated tissue burden, FAILS: studies show only transient circulating-blood particles fall, not tissue burden.

That removal produces a clinical health benefit, FAILS: no study reports any health outcome, and the apheresis tubing itself leaches plastic back in.

The evidence

What the evidence actually shows

Presence is real; the leap to "making you sick" is not

The presence prong is settled. Leslie 2022 (Environment International) found quantifiable plastic particles in 17 of 22 healthy adult blood donors (mean 1.6 µg/mL; PET, PE, PS, PMMA), and Ragusa 2021 ("Plasticenta") found 12 microplastic fragments in 4 of 6 human placentas. Both papers explicitly make no health-harm claim. The strongest human harm signal, Marfella 2024 (NEJM), is a prospective observational cohort of 257 carotid-endarterectomy patients in which plaque positive for microplastics was associated with a higher rate of death, heart attack or stroke (HR 4.53; 95% CI 2.00–10.27). It is an association, not causation, the authors themselves cannot exclude confounding, and independent correspondence flagged possible external plastic contamination of samples. The WHO judged microplastics "do not appear to pose a health risk at current levels" while calling the evidence base limited.

The detox is unsupported, and the filter sheds plastic

The detox prong is the weakest and the most conflicted. The apheresis proof-of-concept (Bornstein 2025, Brain Medicine) detected plastic-like particles (polyamide 6, polyurethane) in discarded blood eluate from 21 samples, it shows particles can appear in the waste, not that tissue burden falls or that anyone gets healthier. The peer-reviewed plasma-exchange study (Weinstein 2026, Journal of Clinical Apheresis; 114 patients) reported a drop in circulating particle counts but no clinical benefit, and crucially found the reduction was "obscured at low starting levels … because of leaching of MP back into the circulation from the plastic apheresis tubing set." Independent experts say plainly there is "no published scientific evidence that microplastics can be effectively filtered from human blood," and advise reducing exposure over paying for a cleanse.

Evidence quality

Studies, graded, and who paid

Microplastics are present in human tissue (blood, placenta, plaque) A High certainty

Replicated with spectroscopy across independent labs; detection is genuine.

Microplastics cause specific human disease C Low certainty

One observational cardiovascular association (Marfella 2024); no causation, contamination and confounding unresolved.

A detox safely removes accumulated microplastics and improves health D Very low certainty

Removal studies measure only blood-eluate particles, show no tissue or outcome benefit, and the filter itself sheds plastic.

Cited studies with type, size, funding/conflicts, and limitations.
#	Study	Type	Size	Funding / COI	Key limitations
22	Leslie 2022, plastic in human blood	Cross-sectional detection (proof of presence)	22 healthy adult donors	Funding unknown Indexed as non-commercial academic; specific funder not stated in abstract.	Detection only; makes no health-harm claim; funder not visible.
6	Ragusa 2021, "Plasticenta"	Cross-sectional detection (proof of presence)	6 human placentas	Funding unknown Indexed 'Research Support, Non-U.S. Gov't'; no commercial conflict identified.	Very small n; detection only; one fragment confirmed polypropylene, rest pigment-identified.
257	Marfella 2024, microplastics in atheroma	Prospective observational cohort (no causation)	257 carotid-endarterectomy patients	Independent Academic (Univ. of Campania Luigi Vanvitelli); reported not industry-funded.	Association only; possible sample contamination; residual confounding; full text paywalled, figures from PubMed/secondary reporting.
0	WHO, microplastics risk assessment	Authoritative risk-assessment review	Evidence synthesis	Independent WHO; no commercial interest.	Concludes evidence base is limited and insufficient for firm toxicity conclusions.
21	Bornstein 2025, apheresis proof-of-concept	Uncontrolled proof-of-concept case series	21 patient eluate samples	Mixed Part NIH (R21 MH126405) but several authors affiliated with commercial apheresis providers (INUS, TKM, Transmedac).	Detects particles in discarded eluate only; no tissue-burden reduction; no clinical outcome.
100	Weinstein 2026, plasma exchange (peer-reviewed)	Sponsor-affiliated clinical case series (no health outcomes)	114 patients / 174 procedures	Industry-funded Authors affiliated with Circulate Health, which sells plasma-exchange services.	Lowers circulating counts only, not tissue burden; no clinical benefit; reduction obscured by plastic leaching from the apheresis tubing.

The same word, "detox", is stretched across three very different claims; conflating proven presence with unproven harm and an unvalidated cure is what makes the marketing misleading.

See who funded the studies behind every Caveat check

Stay neutral

Unproven ≠ disproven

The detox is unproven, not disproven: no rigorous trial has tested whether removing circulating particles changes tissue burden or any health endpoint. Absence of a benefit signal is not the same as a trial showing it fails.

The gap

Where claim and evidence diverge

The gap is between what is measured and what is sold: studies measure plastic particles in blood or in discarded eluate, while the marketing promises you will be sicker without treatment and healthier with it, a clinical claim no study supports.

Follow the funding

The money trail

The detection and harm research is largely independent and academic (Leslie, Ragusa, Marfella, WHO).

Every human "removal" result traces back to commercial apheresis/plasma-exchange providers, Bornstein 2025 co-authored by people affiliated with INUS, TKM and Transmedac, and Weinstein 2026 by authors affiliated with Circulate Health, companies that sell the very service framed as a needed detox.

Bottom line

The honest read

Exposure is real and worth taking seriously, but "microplastics are making you sick and you need a detox" overstates a harm that is still unproven in humans and sells an unvalidated, conflicted procedure as a cure. Reducing exposure is the defensible move; paying for a blood cleanse is not.

Falsifiable

What would change this verdict

A controlled trial showing a microplastic-removal procedure lowers tissue/organ burden and improves a hard clinical outcome, with contamination controls.

Prospective or mechanistic human evidence establishing that microplastic exposure causes a specific disease, not merely associates with it.

Receipts

Sources

Common questions